Sepsis caused by Elizabethkingia miricola successfully treated with tigecycline and levofloxacin

Diagnostic Microbiology and Infectious Disease

Volumn 62, Issue 4, 2008, Pages 430-432

  Green, O'Neil ^a   Murray, Patrick ^b   Gea Banacloche, Juan C ^b  

^a NEW YORK HOSPITAL QUEENS   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Disease; Elizabethkingia; Human; Miricola

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B LIPID COMPLEX; ANIDULAFUNGIN; CARBAPENEM; CARMUSTINE; CASPOFUNGIN; CEFTAZIDIME; CIPROFLOXACIN; COTRIMOXAZOLE; CYTARABINE; ETOPOSIDE; LEVOFLOXACIN; MELPHALAN; MEROPENEM; RIFAMPICIN; TIGECYCLINE; VORICONAZOLE;

ADULT; ARTICLE; BLOOD CULTURE; CASE REPORT; CHRYSEOBACTERIUM; CLINICAL FEATURE; ELIZABETHKINGIA MIRICOLA; HUMAN; MALE; PRIORITY JOURNAL; SEPSIS; TRACHEAL ASPIRATION PROCEDURE;

ANTI-BACTERIAL AGENTS; GRAM-NEGATIVE BACTERIA; GRAM-NEGATIVE BACTERIAL INFECTIONS; HUMANS; LYMPHOMA, MANTLE-CELL; MALE; MIDDLE AGED; MINOCYCLINE; OFLOXACIN; PNEUMONIA, BACTERIAL; PNEUMONIA, VENTILATOR-ASSOCIATED; SEPSIS; STEM CELL TRANSPLANTATION;

EID: 56049105834     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2008.07.015     Document Type: Article

References (3)

1. Bloch K., et al. Chryseobacterium meningosepticum: an emerging pathogen among immunocompromised adults: report of 6 cases and literature review. Medicine (Baltimore) 76 (1997) 30-41
2. Kim K.K., et al. Transfer of Chryseobacterium meningosepticum and Chryseobacterium miricola to Elizabethkingia gen. nov. as Elizabethkingia meningoseptica comb. nov. and Elizabethkingia miricola comb. nov. Int. J. Syst. Evol. Microbiol. 55 (2005) 1287-1293
3. Li Y., et al. Chryseobacterium miricola sp. nov., novel species isolated from condensation water of space station Mir. Syst. Appl. Microbiol. 26 (2003) 523-528